Atossa Therapeutics
ATOS
#10043
Rank
ยฃ30.53 M
Marketcap
ยฃ3.55
Share price
-0.63%
Change (1 day)
383.37%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ0.01 M-98.27%
2025ยฃ0.59 M-68.3%
2024ยฃ1.86 M265.91%
2023ยฃ0.5 M-93.57%
2022ยฃ7.92 M-92.88%
2021ยฃ0.11 B731.9%
2020ยฃ13.37 M-10.09%
2019ยฃ14.87 M138.47%
2018ยฃ6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ67.61 Mยฃ0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ7.75 Mยฃ58.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ7.86 Mยฃ31.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ0.05 Mยฃ13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ1.78 Mยฃ6.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
N/Aยฃ0.17 M๐Ÿ‡บ๐Ÿ‡ธ USA